ArticleEJNMMI reports2025
Enhanced attenuation correction in FDG-PET/CT with respiratory mismatch correction.
Article in EJNMMI reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn positron emission tomography/computed tomography (PET/CT), CT is typically used for attenuation correction during the creation and reconstruction of PET images. Respiratory motion can cause artifacts due to misalignment of PET images, known as respiratory misalignment artifacts (RMA), which occur in up to 30% of lesion-based evaluations, often necessitating rescans of both PET and CT. A new method for reconstructing PET/CT artifacts caused by respiratory motion, termed 'Enhanced AC' (EAC) (GE HealthCare, USA), was developed to improve RMA. To evaluate the effectiveness of EAC, radiologists' visual assessment using a misalignment score is appropriate regardless of the presence or absence of target lesions. This study aimed to assess the usefulness of EAC based on radiologist evaluations.
methodsConsecutive F-18 fluorodeoxyglucose (FDG) PET/CT cases imaged at our hospital between July and August 2024 were included. Two radiologists independently assessed the deviation of FDG-PET/CT images from all cases imaged conventionally. Cases identified by either radiologist as misaligned were designated as the misalignment case group and used for evaluating EAC. A 5-point scoring system was established for the misalignment score. To evaluate the effect of EAC, PET coronal section images from the misalignment case group before EAC adaptation (pre-images) and the EAC-reconstructed images (EAC images) were displayed side by side. Five radiologists independently evaluated both images using a misalignment score.
resultsFifty-four patients (male/female = 36/18, average age 64.1 ± 15.0 years, median 66.5 years) were identified as the misalignment case group. The average misalignment scores from the five radiologists for the pre-images were 3.5, 3.4, 3.3, 3.1, and 3.1, respectively, whereas the scores for the EAC images were significantly lower (p < 0.01) across all radiologists: 2.1, 2.4, 2.5, 2.2, and 1.9, respectively.
conclusionsEAC is an effective and practical method for reducing RMA in selected cases. This method can be easily tailored to individual patients and does not require a large, deep-learning dataset, making it suitable for routine diagnostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.